|
 |
|
|
Premier Research is developing a breadth of experience in the increasingly important therapeutic areas of Cardiovascular and Respiratory research.
Cardiovascular
Premier Research has a long tradition in cardiovascular clinical research. The company has been involved in the evolution of data collection and monitoring of cardiotoxicity data for new molecular entities. Since 1998 Premier Research has assisted with more than 105 projects in this area including supporting post-approval studies critical in the treatment of various cardiovascular conditions including hypertension, and the collection and reporting of data supporting a global registry study for Acute Coronary Events. Expanding services to Central and Eastern Europe, Premier Research has conducted study management for Phase III studies including angina, hypercholesterolemia, myocardial infarction and peripheral vascular disease. We remain heavily engaged in this area with highly efficient and productive investigators and institutions internationally.
Respiratory
Since the mid 1990s, Premier Research has supplied services to companies specialized in the investigation and development of drugs treating a range of respiratory conditions, such as allergic rhinitis, asthma, bronchitis and COPD. Our PPA process allows Premier Research to manage and effectively complete groups of like-designed studies which support rapid drug development. For example, in 2005 Premier Research completed data entry, query resolution, and database lock for 9 studies in 11 weeks with statistical analysis and final study report issuance of all 9 studies within 5 weeks of the last database locked, all to support critical client submission deadlines. For this therapeutic area, 100% of our sponsors have returned to Premier Research for additional work.
|
|
 |
|